Topical Cryotherapy and Keloid/Hypertrophic Scars
NCT: NCT07336368 · RECRUITING
Brief Summary
The goal of this clinical trial is to determine whether the application of brief topical cryotherapy immediately before intralesional corticosteroid injections can reduce pain and injection resistance during routine treatment of keloid and hypertrophic scars in adult patients. The main questions it aims to answer are: Does topical cryotherapy applied before intralesional triamcinolone injection impact pain perceptions for participants with keloids or hypertrophic scars? Does topical cryotherapy affect provider-assessed injection resistance compared with standard injection alone? Researchers will split the keloid/hypertrophic scar into two halves. One half will be treated with cryotherapy followed by steroid injection, while the other half will be treated with steroid injection alone to evaluate differences in pain perception and injection resistance. Participants will rate pain after each injection using a 10-point numeric pain scale. Clinicians will rate the resistance after each injection using a 10-point numeric scale.
Frequently Asked Questions
What is Topical Cryotherapy and Keloid/Hypertrophic Scars?
Topical Cryotherapy and Keloid/Hypertrophic Scars is a clinical trial registered under NCT07336368. Current status: RECRUITING.
What is the status of NCT07336368?
The current status of NCT07336368 (Topical Cryotherapy and Keloid/Hypertrophic Scars) is: RECRUITING.
When did Topical Cryotherapy and Keloid/Hypertrophic Scars start?
Topical Cryotherapy and Keloid/Hypertrophic Scars started on 2026-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.